QuidelOrtho Corp. (QDEL) intrinsic value & 10-year financials
QuidelOrtho Corp. (QDEL) has a Graham intrinsic value of $495.27 per share. At $12.91 on Oct 17, 2026, the stock trades 97% below that value. Over the last 6 fiscal years revenue grew 13.2% a year to $2.7B, with an average return on invested capital of 3.4%.
- Graham intrinsic value
- $495.27
- Share price (Oct 17, 2026)
- $12.91
- Price vs Graham value
- 97% below
- Market cap
- $875.3M
- Revenue (FY2025)
- $2.7B
- Revenue growth (6-yr CAGR)
- 13.2%
- ROIC (10-yr avg)
- 3.4%
- Free cash flow (FY2025)
- -$83.0M
QDEL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.7B | -$1.1B | -$16.69 | -$83.0M | -33.7% | -19.9% |
| FY2024 | $2.8B | -$2.1B | -$30.54 | -$112.1M | -70.5% | -31.0% |
| FY2023 | $3.0B | -$10.1M | -$0.15 | $70.9M | 4.6% | 1.7% |
| FY2022 | $1.7B | $704.2M | $16.43 | $513.1M | 53.3% | 62.9% |
| FY2021 | $1.7B | $810.3M | $18.60 | $564.8M | 63.8% | — |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
QuidelOrtho Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
QuidelOrtho Corp has historically struggled to out-earn its cost of capital, averaging just 3.4% ROIC.
QuidelOrtho Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, QuidelOrtho Corp is modeled at 13.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $495.27 per share.